查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1869755

神經介入器材市場規模、佔有率和趨勢分析報告：按產品、適應症、最終用途、地區和細分市場預測（2025-2033 年）

Neurointerventional Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic Devices, Therapeutic Devices), By Indication (Acute Ischemic Stroke (AIS), Intracranial Aneurysm), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

神經介入器材市場摘要

2024年全球神經介入設備市場規模估計為29.5億美元，預計2033年將達到49.6億美元。

預計從 2025 年到 2033 年，該市場將以 5.9% 的複合年成長率成長。推動該市場成長要素是中風、腦動脈瘤、血管畸形和其他神經血管疾病的盛行率不斷上升，以及老年人口的快速成長，而老年人更容易患上這些疾病。

與開放性手術相比，微創手術恢復更快、併發症更少，其日益成長的需求進一步推動了市場成長。中風、動脈瘤和其他神經血管疾病等神經系統疾病發生率的上升是神經介入器材市場的主要驅動力，因為這增加了對有效微創治療的需求，這些治療有望減少殘疾、提高生存率並老齡化患者預後。世界神經病學聯合會（WFN）指出，神經系統疾病的盛行率在不同年齡層之間存在差異，包括早產兒、新生兒、兒童、青少年、成人和老年人，老年人通常面臨與年齡相關的多種疾病和體弱問題。 2024年全球疾病負擔研究估計，屆時全球43%的人口將受到神經系統疾病的影響，凸顯了全球對神經介入器材和治療方法的巨大需求。

技術進步，例如新一代血栓摘取支架、血流導向裝置和先進的影像解決方案，正在改善治療效果。新興市場加快監管核准、改善報銷政策以及擴大醫療基礎設施，正在推動介入神經放射學器材的廣泛應用。例如，2024年4月，《神經病學》雜誌發表的預測顯示，到2050年，全球腦部疾病病例將達到49億例，比2021年增加22%。預計全球各年齡層腦部疾病的失能調整後存活年（DALY）率也將顯著上升10%，從2021年的每10萬人5139 DALY上升到2050年的每10萬人5666 DALY。頭痛、阿茲海默症、憂鬱症和焦慮症以及中風已被認為是導致腦部疾病盛行率和疾病負擔預計激增的主要因素。

中風（尤其是缺血性中風）發病率的上升，推動了神經介入器材市場的發展，因為人們對高效、微創的取栓手術的需求日益成長。例如，根據美國疾病管制與預防中心（CDC）2024年的數據（見下表），美國每年將有超過79.5萬人發生中風，顯示對先進的介入神經放射學治療方法的需求不斷增加。世界衛生組織（WHO）估計，全球每年約有1500萬人發生中風，其中約87%為缺血性中風。

根據世界中風組織 (WSO) 2022 年的報告，下表顯示了缺血性中風的發生率和盛行率。

根據《實驗性中風與轉化醫學雜誌》的報告，出血性中風約佔所有病例的 10-15%，當血管破裂時，會導致血液流入腦組織（腦出血）或腦周圍空間（蛛網膜下腔出血）。

動靜脈畸形（AVM）是推動神經介入器材市場成長的關鍵因素，因為這些複雜的血管畸形需要精準且微創的治療方法。先進影像技術的進步提高了AVM的檢出率，並且人們越來越傾向於選擇血管內治療而非開放性手術，這些因素共同推動了對栓塞系統、導管和彈簧圈等專用神經介入器械的需求。醫療專業人員日益認知到早期療育對於預防出血併發症的重要性，這進一步加速了先進介入神經放射學解決方案在AVM治療中的應用。根據美國美國生物技術資訊中心（NCBI）發表的一項研究，約15%的動靜脈畸形（AVM）在出現臨床症狀之前通常無症狀。 41%至79%的AVM患者會出現顱內出血。蜘蛛網膜下腔出血是繼腦動脈瘤之後導致顱內出血的第二大原因，約佔所有蜘蛛網膜下腔出血的 10%。

人口老化正在推動神經血管治療器械市場的發展。老年人更容易患有神經血管疾病，例如中風、動脈瘤和與老齡化相關的腦血管疾病。這種人口結構變化正在推動對微創治療方法和先進神經血管器械的需求。例如，根據腦動脈瘤基金會2024年6月發布的數據，美國估計有680萬人（約佔總人口的1/50）患有未破裂的腦動脈瘤，年破裂率為每10萬人8至10例。每年約有3萬美國人發生腦動脈瘤破裂，平均每18分鐘就有一例。全球每年約有50萬人死於腦動脈瘤，其中一半患者年齡在50歲以下。大多數動脈瘤發生在40歲以後，發生率最高的年齡層為35至60歲。兒童也可能患上動脈瘤。腦動脈瘤在女性的發生率高於男性（男女比例約3:2），55歲以上女性的動脈瘤破裂風險約為男性的1.5倍。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 神經介入器材市場變數、趨勢與範圍

  • 市場體系展望
    • 附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 神經介入設備市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章 神經介入器材市場：產品估算與趨勢分析

  • 細分儀表板
  • 神經介入器材市場：產品差異分析及市場佔有率（2024 年及 2030 年）
  • 診斷設備
  • 治療設備

第5章 神經介入器材市場：適應症與趨勢分析

  • 細分儀表板
  • 神經介入器材市場：自適應變化分析及市場佔有率（2024 年及 2030 年）
  • 急性缺血性腦中風（AIS）
  • 顱內動脈瘤
  • 腦動脈狹窄
  • 動靜脈畸形（AVM）
  • 椎血管畸形

第6章 神經介入器材市場：終端用戶估算與趨勢分析

  • 細分儀表板
  • 神經介入器材市場：最終用途差異分析及市場佔有率（2024 年及 2030 年）
  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第7章 神經介入器材市場：區域估算與趨勢分析

  • 區域展望
  • 神經介入器材市場：區域差異分析及市場佔有率（2024 年及 2030 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • Terumo Neuro
    • NeuroSafe Medical Co., Ltd
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • Brain Navi Biotechnology Co., Ltd.
    • Medtronic
    • Stryker
    • CERENOVUS（Johnson &Johnson）
    • Integra LifeSciences Corporation
    • Penumbra Inc
    • Balt SAS
    • B. Braun SE
    • Phenox GmbH
    • Shanghai MicroPort Medical（Group）Co. Ltd.
    • Boston Scientific Corporation
    • Meril
    • Gem srl
    • Sirtex（BlackSwan Vascular, Inc.）
    • INVAMED
    • Merit Medical Systems
    • Abbott
    • Acandis GmbH
    • Cook Medical
    • Imperative Care, Inc.
    • Rapid Medical
    • Koninklijke Philips NV
    • KANEKA CORPORATION
  • 熱力圖分析/企業市場分析
  • 公司市佔率分析，2024 年
Product Code: GVR-4-68040-776-9

Neurointerventional Devices Market Summary

The global neurointerventional devices market size was estimated at USD 2.95 billion in 2024 and is projected to reach USD 4.96 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is primarily driven by the rising prevalence of stroke, brain aneurysms, vascular malformations and other neurovascular disorders, coupled with the rapidly growing aging population prone to such conditions.

Increasing demand for minimally invasive procedures, which offer faster recovery and fewer complications than open surgery, further accelerates market growth. The rising incidence of neurological disorders such as stroke, aneurysms, and other neurovascular conditions is a key driver of the neurointerventional devices market, as it increases the demand for effective, minimally invasive treatments that can reduce disability, improve survival rates, and enhance patient outcomes. According to the World Federation of Neurology (WFN), neurological disease prevalence varies across age groups, including preterm, neonatal, childhood, adolescent, adult, and older adults who often experience age-related multimorbidity and frailty. The 2024 Global Burden of Disease study estimated that 43% of the world's population is affected by a neurological disorder, underscoring the significant global demand for neurointerventional devices and treatments.

Technological advancements, including next-generation stent retrievers, flow diverters, and advanced imaging solutions, enhance treatment outcomes. Favorable regulatory approvals, improved reimbursement policies, and expanding healthcare infrastructure in emerging markets are supporting wider adoption of neurointerventional devices. For instance, in April 2024, Neurology journals have highlighted projections estimating that the number of brain disorder cases could reach 4.9 billion globally by 2050, marking a 22% increase compared to 2021. The all-age Disability-Adjusted Life Years (DALYs) rate of brain disorders is also expected to rise significantly by 10% globally, from 5,139 DALYs per 100,000 in 2021 to 5,666 DALYs per 100,000 in 2050. Headaches, Alzheimer's disease, depressive and anxiety disorders, and strokes are identified as the primary contributors to this anticipated surge in prevalence and disease burden.

The rising incidence of stroke, particularly ischemic stroke is propelling the neurointerventional devices market by increasing the demand for efficient and minimally invasive clot removal procedures. For instance, in 2024, CDC data highlighted, as presented in the table below, that over 795,000 people in the U.S. suffer a stroke each year, emphasizing the growing need for advanced neurointerventional treatment options.[ According to the WHO, the global incidence of stroke is estimated to be approximately 15 million people annually, with ischemic stroke representing about 87% of all stroke cases.

According to the World Stroke Organization 2022, the table below shows the incidence and prevalence of ischemic stroke.

According to the Journal of Experimental Stroke & Translational Medicine, Hemorrhagic stroke accounts for approximately 10-15% of cases and results from the rupture of a blood vessel, causing bleeding within the brain tissue (intracerebral hemorrhage) or into the space surrounding the brain (subarachnoid hemorrhage).

Arteriovenous malformations (AVMs) are a significant factor driving the growth of the neurointerventional devices market, as these complex vascular abnormalities require precise and minimally invasive treatment approaches. The increasing detection of AVMs through advanced imaging techniques and the growing preference for endovascular procedures over open surgery fuel the demand for specialized neurointerventional devices such as embolization systems, catheters, and coils. Rising awareness among healthcare professionals about early intervention to prevent hemorrhagic complications further accelerates the adoption of advanced neurointerventional solutions for AVM management. According to a research article published by the National Center for Biotechnology Information, arteriovenous malformations (AVMs) are often asymptomatic in about 15% of cases until a clinical event occurs. Between 41% and 79% of AVMs are present with intracranial hemorrhage. They are the second most common cause of intracranial bleeding after cerebral aneurysms, accounting for approximately 10% of all subarachnoid hemorrhages.

The growing aging population drives the neurointerventional devices market, as older adults are more prone to neurovascular conditions such as stroke, aneurysms, and age-related cerebrovascular diseases. This demographic trend increases the demand for minimally invasive interventions and advanced neurovascular devices. For instance, in June 2024, the Brain Aneurysm Foundation reported that an estimated 6.8 million people in the United States, about 1 in 50, have an unruptured brain aneurysm, with an annual rupture rate of 8-10 per 100,000 people. Each year, roughly 30,000 Americans experience a brain aneurysm rupture, which occurs on average every 18 minutes. Globally, brain aneurysms cause nearly 500,000 deaths annually, with half of the victims under 50. While most aneurysms develop after age 40 and are most common between ages 35 to 60, they can also occur in children. Women are more likely than men to have a brain aneurysm (3:2 ratio), and women over 55 faces approximately 1.5 times higher risk of rupture than men.

Global Neurointerventional Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global neurointerventional devices market report based on product, indication, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic Devices
    • Catheters
    • Distal Access Catheters
    • Microcatheters
    • Others
    • Guidewires
    • Imaging Systems
  • Therapeutic Devices
    • Embolic Materials
    • Embolic Coils
    • Embolic Agents
    • Neurovascular Stents
    • Self-Expanding Stents
    • Balloon-Expandable Stents
    • Flow Diverter Stents
    • Coil-Assist Stents
    • Neurothrombectomy Devices
    • Intrasaccular Devices
    • Embolic Protection Devices
    • Others
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Acute Ischemic Stroke (AIS)
  • Intracranial Aneurysm
  • Cerebral Arterial Stenosis
  • Arteriovenous Malformation (AVM)
  • Spinal Vascular Malformations
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Product
    • 1.2.3. Indication
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurointerventional Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Incidence of Neurovascular Disorders
      • 3.2.1.2. Growing Preference for Minimally Invasive Procedures
      • 3.2.1.3. Regulatory Approvals and Reimbursement Policies
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High procedural and device costs
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising prevalence of stroke and cerebrovascular disorders
      • 3.2.3.2. Integration of AI and robotics
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Complexity of neurovascular anatomy
      • 3.2.4.2. Device-related risks and failures
  • 3.3. Neurointerventional Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Neurointerventional Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurointerventional Devices Market: Product Movement Analysis & Market Share, 2024 & 2030
  • 4.3. Diagnostic Devices
    • 4.3.1. Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.1. Catheters
        • 4.3.1.1.1. Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.1. Distal Access Catheters
            • 4.3.1.1.1.1.1. Distal Access Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.2. Microcatheters
            • 4.3.1.1.1.1.2. Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.3.1.1.1.3. Others
            • 4.3.1.1.1.1.3. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.2. Guidewires
        • 4.3.1.1.2. Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.1.3. Imaging Systems
        • 4.3.1.3.1. Imaging Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Therapeutic Devices
    • 4.4.1. Therapeutic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Embolic Materials
        • 4.4.1.1.1. Embolic Materials Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.1. Embolic Coils
            • 4.4.1.1.1.1.1. Embolic Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.2. Embolic Agents
            • 4.2.1.1.1.2.1. Embolic Agents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.2. Neurovascular Stents
        • 4.4.1.2.1. Neurovascular Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.1. Self-Expanding Stents
            • 4.4.1.2.1.1.1. Self-Expanding Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.2. Balloon-Expandable Stents
            • 4.4.1.2.1.2.1. Balloon-Expandable Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.3. Flow Diverter Stents
            • 4.4.1.2.1.3.1. Flow Diverter Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.2.1.4. Coil-Assist Stents
            • 4.4.1.2.1.4.1. Coil-Assist Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.3. Neurothrombectomy Devices
        • 4.4.1.3.1. Neurothrombectomy Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.4. Intrasaccular Devices
        • 4.4.1.4.1. Intrasaccular Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.5. Embolic Protection Devices
        • 4.4.1.5.1. Embolic Protection Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.6. Others
        • 4.4.1.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurointerventional Devices Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurointerventional Devices Market: Indication Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Acute Ischemic Stroke (AIS)
    • 5.3.1. Acute Ischemic Stroke (AIS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Intracranial Aneurysm
    • 5.4.1. Intracranial Aneurysm Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cerebral Arterial Stenosis
    • 5.5.1. Cerebral Arterial Stenosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Arteriovenous Malformation (AVM)
    • 5.6.1. Arteriovenous Malformation (AVM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Spinal Vascular Malformations
    • 5.7.1. Spinal Vascular Malformations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurointerventional Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Neurointerventional Devices Market: End Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Specialty Clinics
    • 6.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Ambulatory Surgery Centers
    • 6.5.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurointerventional Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Neurointerventional Devices Market: Regional Movement Analysis & Market Share, 2024 & 2030
  • 7.3. North America
    • 7.3.1. North America Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Terumo Neuro
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Technology Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. NeuroSafe Medical Co., Ltd
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Technology Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Technology Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Brain Navi Biotechnology Co., Ltd.
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Technology Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Medtronic
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Technology Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Stryker
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Technology Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. CERENOVUS (Johnson & Johnson)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Technology Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Integra LifeSciences Corporation
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Technology Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Penumbra Inc
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Technology Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Balt SAS
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Technology Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. B. Braun SE
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Technology Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Phenox GmbH
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Technology Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. Shanghai MicroPort Medical (Group) Co. Ltd.
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Technology Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Boston Scientific Corporation
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Technology Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Meril
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Technology Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Gem srl
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Technology Benchmarking
      • 8.2.16.4. Strategic Initiatives
    • 8.2.17. Sirtex (BlackSwan Vascular, Inc.)
      • 8.2.17.1. Company Overview
      • 8.2.17.2. Financial Performance
      • 8.2.17.3. Technology Benchmarking
      • 8.2.17.4. Strategic Initiatives
    • 8.2.18. INVAMED
      • 8.2.18.1. Company Overview
      • 8.2.18.2. Financial Performance
      • 8.2.18.3. Technology Benchmarking
      • 8.2.18.4. Strategic Initiatives
    • 8.2.19. Merit Medical Systems
      • 8.2.19.1. Company Overview
      • 8.2.19.2. Financial Performance
      • 8.2.19.3. Technology Benchmarking
      • 8.2.19.4. Strategic Initiatives
    • 8.2.20. Abbott
      • 8.2.20.1. Company Overview
      • 8.2.20.2. Financial Performance
      • 8.2.20.3. Technology Benchmarking
      • 8.2.20.4. Strategic Initiatives
    • 8.2.21. Acandis GmbH
      • 8.2.21.1. Company Overview
      • 8.2.21.2. Financial Performance
      • 8.2.21.3. Technology Benchmarking
      • 8.2.21.4. Strategic Initiatives
    • 8.2.22. Cook Medical
      • 8.2.22.1. Company Overview
      • 8.2.22.2. Financial Performance
      • 8.2.22.3. Technology Benchmarking
      • 8.2.22.4. Strategic Initiatives
    • 8.2.23. Imperative Care, Inc.
      • 8.2.23.1. Company Overview
      • 8.2.23.2. Financial Performance
      • 8.2.23.3. Technology Benchmarking
      • 8.2.23.4. Strategic Initiatives
    • 8.2.24. Rapid Medical
      • 8.2.24.1. Company Overview
      • 8.2.24.2. Financial Performance
      • 8.2.24.3. Technology Benchmarking
      • 8.2.24.4. Strategic Initiatives
    • 8.2.25. Koninklijke Philips N.V.
      • 8.2.25.1. Company Overview
      • 8.2.25.2. Financial Performance
      • 8.2.25.3. Technology Benchmarking
      • 8.2.25.4. Strategic Initiatives
    • 8.2.26. KANEKA CORPORATION
      • 8.2.26.1. Company Overview
      • 8.2.26.2. Financial Performance
      • 8.2.26.3. Technology Benchmarking
      • 8.2.26.4. Strategic Initiatives
  • 8.3. Heat Map Analysis/ Company Market Position Analysis
  • 8.4. Company Market Share Analysis, 2024

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 6 North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 9 U.S. North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 11 Canada Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 12 Canada North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Mexico Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 14 Mexico Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 15 Mexico North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Europe Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 17 Europe Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 18 Europe Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 19 Europe North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 20 UK Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 21 UK Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 22 UK Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 23 Germany Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 24 Germany Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 25 Germany Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 26 France Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 27 France Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 28 France Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Italy Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 30 Italy Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 31 Italy Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Spain Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 33 Spain Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 34 Spain Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Norway Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 36 Norway Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 37 Norway Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Sweden Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 39 Sweden Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 40 Sweden Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Denmark Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 42 Denmark Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 43 Denmark Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 48 China Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 49 China Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 50 China Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 51 Japan Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 53 Japan Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 54 India Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 55 India Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 56 India Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Australia Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 58 Australia Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 59 Australia Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 62 South Korea Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Thailand Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 64 Thailand Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 65 Thailand Korea Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Latin America Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 67 Latin America Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 68 Latin America Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 69 Latin America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Brazil Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 71 Brazil Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 72 Brazil Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Argentina Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 74 Argentina Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 75 Argentina Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Middle East & Africa Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
  • Table 77 Middle East & Africa Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 78 Middle East & Africa Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 80 South Africa Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 81 South Africa Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 82 South Africa Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 85 Saudi Arabia Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 86 UAE Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 87 UAE Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 88 UAE Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
  • Table 89 Kuwait Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
  • Table 90 Kuwait Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
  • Table 91 Kuwait Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Neurointerventional devices market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Neurointerventional devices market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping, by Technology
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Market opportunity analysis (Current & future impact)
  • Fig. 13 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Diagnostic devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Imaging systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Therapeutic devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Embolic materials market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Neurovascular stents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Neurothrombectomy devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Intrasaccular devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Embolic protection devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Acute ischemic stroke (AIS) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Cerebral arterial stenosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Arteriovenous malformation (AVM) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Spinal vascular malformations market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Neurointerventional devices market: Regional key takeaways (USD Million)
  • Fig. 35 Neurointerventional devices market: Regional outlook, 2021 & 2030, USD Million
  • Fig. 36 North America Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Canada Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Europe Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 UK Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Germany Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 France Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Spain Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Italy Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Sweden Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Norway Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Asia Pacific Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 China Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 India Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 South Korea Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Australia Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Thailand Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Latin America Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Brazil Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Argentina Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Middle East and Africa Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 South Africa Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Kuwait Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 List of key emerging companies
  • Fig. 65 Company market share analysis, 2024
  • Fig. 66 Market differentiators
  • Fig. 67 Competitive dashboard analysis
  • Fig. 68 Regional network map